Nixon Peabody LLP has announced new
leadership for the firm's Litigation and Intellectual Property department.
Boston partner Ronald I. Eisenstein will be joining partner David Resnick as
Co-Leader of the firm's Patents practice.
"It is increasingly important for our clients to protect and maximize the
full value of their intellectual property assets. Our attorneys are among the
best-suited to help clients achieve these goals through their deep knowledge of
engineering, biotechnology and life sciences, and excellent business judgment to
every business and legal challenge," said Jennifer A. Kuenster, Chair of Nixon
Peabody's Litigation and Intellectual Property Department.
Ron represents major U.S. research institutions, U.S. companies, and
foreign corporations in handling interferences before the U.S. Patent and
Trademark Office, which have involve personalized medicine, cancer vaccines,
gene therapy, diagnostics and medical devices. He also has extensive experience
in prosecuting biotechnology, medical, and chemical cases, and counseling with
respect to strategic management of the intellectual property
portfolios. Ron earned his J.D. from Georgetown University Law Center and
received a B.S. from Cornell University.
"Our patents practice is seeing a great deal of work as the current economy
is keeping intellectual property assets on the forefront of our clients' minds,"
Ms. Kuenster added. "Ron's depth of experience in all patent issues, from due
diligence to transactional matters to prosecution, well-position him to join
David in this leadership role."